Geode Capital Management
ATTO

Geode Capital Management’s Attovia Therapeutics ATTO Stock Holding History

Geode Capital Management’s Portfolio ATTO Stock Details ATTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.54M Buy
+206,176
New +$4.34M ﹤0.01% 3010

Other funds holding ATTO

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Geode Capital Management's ATTO Position: Q3 2026 in Review

Geode Capital Management opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 206,176 shares worth $3.54M. The stake represents ﹤0.01% of the portfolio and ranks #3010 among its holdings.

4 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Geode Capital Management held 206,176 shares of Attovia Therapeutics worth $3.54M as of Q3 2026.
  • Attovia Therapeutics was a new Geode Capital Management position in Q3 2026.
  • Attovia Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3010 holding.
  • 4 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.